Otro
Crotoxin: Novel activities for a classic beta-neurotoxin
Registro en:
Toxicon. Oxford: Pergamon-Elsevier B.V. Ltd, v. 55, n. 6, p. 1045-1060, 2010.
0041-0101
10.1016/j.toxicon.2010.01.011
WOS:000276436600001
Autor
Sampaio, Sandra C.
Hyslop, Stephen
Fontes, Marcos R. M.
Prado-Franceschi, Julia
Zambelli, Vanessa O.
Magro, Angelo J.
Brigatte, Patricia
Gutierrez, Vanessa P.
Cury, Yara
Resumen
Crotoxin, the main toxin of South American rattlesnake (Crotalus durissus terrificus) venom, was the first snake venom protein to be purified and crystallized. Crotoxin is a heterodimeric beta-neurotoxin that consists of a weakly toxic basic phospholipase A(2) and a nonenzymatic, non-toxic acidic component (crotapotin). The classic biological activities normally attributed to crotoxin include neurotoxicity, myotoxicity, nephrotoxicity and cardiotoxicity. However, numerous studies in recent years have shown that crotoxin also has immunomodulatory, anti-inflammatory, anti-microbial, anti-tumor and analgesic actions. In this review, we describe the historical background to the discovery of crotoxin and its main toxic activities and then discuss recent structure-function studies and investigations that have led to the identification of novel pharmacological activities for the toxin. (C) 2010 Elsevier Ltd. All rights reserved.